TXN and ovarian cancer: In conclusion, the GnRH-R in ovarian cancer cells likely serves as a docking place for our GnRH-mitoxantrone conjugates, Con-3 and Con-7, which concentrates the mitoxantrone near the cell surface and exposes it to the extracellular thioredoxin system for release.